Eikon Therapeutics Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for Eikon Therapeutics stock have an average target of 25.6, with a low estimate of 7.00 and a high estimate of 34. The average target predicts an increase of 199.07% from the current stock price of 8.56.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$7.00	$25.6	$29	$34
Change	-18.22%	+199.07%	+238.79%	+297.20%

Analyst Ratings

The average analyst rating for Eikon Therapeutics stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Mar '26	Apr '26
Strong Buy	1	1
Buy	4	4
Hold	0	0
Sell	1	1
Strong Sell	0	0
Total	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Robert Driscoll Wedbush	Wedbush	Sell Reiterates $7	Sell	Reiterates	$7	-18.22%	Mar 31, 2026
Imogen Mansfield Cantor Fitzgerald	Cantor Fitzgerald	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Mar 2, 2026
Brian Cheng JP Morgan	JP Morgan	Buy Initiates $29	Buy	Initiates	$29	+238.79%	Mar 2, 2026
Jason Zemansky B of A Securities	B of A Securities	Strong Buy Initiates $34	Strong Buy	Initiates	$34	+297.20%	Mar 2, 2026
Joseph Catanzaro Mizuho	Mizuho	Buy Initiates $26	Buy	Initiates	$26	+203.74%	Mar 2, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-6.74

from -115.29

EPS Next Year

-6.25

from -6.74

Fiscal Year	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028
Period Ending	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028
Revenue	-	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-
EPS	-119.43	-96.76	-115.29	-6.74	-6.25	-6.13
EPS Growth	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-
No. Analysts	-	-	-	8	7	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-6.27	-5.08
Avg	-6.74	-6.25
Low	-7.28	-6.64

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.